V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213792 | 20178163 | 1.63 | 80 | Palliative (P) | 2017-09-05 | 2017-10-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101371701 |
| 20213805 | 20178164 | 1.66 | 93.7 | Palliative (P) | 2019-04-11 | 2019-04-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101640304 |
| 20213885 | 20178165 | 1.76 | 52 | Palliative (P) | 2020-07-01 | 2020-07-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101257790 |
| 20213931 | 20178166 | 1.61 | 73.5 | Palliative (P) | 2021-02-20 | 2021-06-29 | Docetaxel | 02 | N | DOCETAXEL | 100954852 |
| 20213933 | 20178167 | 1.63 | 58.2 | Palliative (P) | 2018-01-14 | 2018-01-26 | Docetaxel | 02 | N | DOCETAXEL | 101123551 |
| 20213962 | 20178168 | 1.91 | 93.5 | Palliative (P) | 2020-07-24 | 2020-10-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101174116 |
| 20213971 | 20178169 | 1.63 | null | null | 2019-06-14 | 2019-06-17 | Docetaxel | 02 | null | DOCETAXEL | 100541274 |
| 20213972 | 20178170 | 1.63 | 56.8 | null | 2021-04-18 | 2021-05-21 | Docetaxel 75mg/m2 (21 day) | null | null | DOCETAXEL | 101055746 |
| 20213986 | 20178171 | 1.78 | 80 | Palliative (P) | 2018-09-24 | 2018-10-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101060303 |
| 20213989 | 20178172 | 1.7 | 79.6 | Adjuvant (A) | 2019-12-09 | 2019-12-15 | Docetaxel | 02 | N | DOCETAXEL | 100571435 |
| 20213990 | 20178173 | 1.48 | 71.05 | Palliative (P) | 2022-02-27 | 2022-03-20 | Cetuximab + FOLFIRI cycle1 | N | N | CAPECITABINE + GEMCITABINE | 101798496 |
| 20214010 | 20178175 | 1.66 | 105.9 | Palliative (P) | 2021-06-07 | 2021-06-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101644129 |
| 20214022 | 20178176 | 1.67 | 69.3 | null | 2020-01-10 | 2020-02-24 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100116619 |
| 20214034 | 20178177 | 1.67 | 98 | Adjuvant (A) | 2021-01-12 | 2021-01-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101700801 |
| 20214056 | 20178179 | 1.74 | 56.6 | Palliative (P) | 2018-12-02 | 2019-08-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100582631 |
| 20214060 | 20178180 | 1.54 | 94.5 | null | 2019-09-21 | 2019-09-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101161973 |
| 20214066 | 20178181 | 1.52 | 104 | Palliative (P) | 2019-06-29 | 2019-09-16 | Docetaxel | 01 | N | DOCETAXEL | 101842137 |
| 20214068 | 20178182 | 1.77 | 53.3 | Palliative (P) | 2018-11-05 | 2018-11-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100815352 |
| 20214069 | 20178183 | 1.53 | 81.6 | Palliative (P) | 2020-05-14 | 2020-05-24 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100599960 |
| 20214130 | 20178184 | 1.6 | 89 | null | 2021-01-20 | 2021-02-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100660410 |
| 20214133 | 20178185 | null | 67 | Adjuvant (A) | 2022-04-19 | 2022-04-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100855387 |
| 20214158 | 20178186 | 1.68 | 63.6 | Palliative (P) | 2020-08-22 | 2020-08-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100448634 |
| 20214166 | 20178187 | 1.7 | 70.9 | Palliative (P) | 2018-07-26 | 2018-08-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100353394 |
| 20214171 | 20178188 | null | 70 | Curative (C) | 2019-08-10 | 2019-09-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101072474 |
| 20214182 | 20178189 | 1.68 | 76.9 | null | 2019-10-02 | 2019-10-11 | Docetaxel | 02 | null | DOCETAXEL | 101756387 |
| 20214206 | 20178190 | 1.66 | 73.1 | null | 2017-11-25 | 2018-01-05 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101809770 |
| 20214211 | 20178191 | 1.63 | 51.8 | null | 2020-07-15 | 2020-12-24 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100292186 |
| 20214216 | 20178192 | 1.61 | 57 | Adjuvant (A) | 2019-02-10 | 2019-02-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101466859 |
| 20214228 | 20178193 | null | 58.3 | Adjuvant (A) | null | 2019-11-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100049192 |
| 20214233 | 20178194 | 1.88 | 99 | Palliative (P) | 2021-08-03 | 2021-08-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | Y | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100402158 |
| 20214240 | 20178195 | 1.76 | 69 | Palliative (P) | 2018-10-15 | 2018-11-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100319630 |
| 20214244 | 20178196 | 1.76 | 67.6 | null | 2021-05-02 | 2021-05-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101565299 |
| 20214262 | 20178197 | 1.84 | 93.3 | null | 2020-01-09 | 2020-01-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100604332 |
| 20214271 | 20178198 | 0 | 67.8 | Palliative (P) | 2019-11-21 | 2020-01-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100854519 |
| 20214272 | 20178199 | 1.65 | 62.3 | Palliative (P) | 2018-11-24 | 2018-12-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100271370 |
| 20214273 | 20178200 | 1.93 | 99.3 | Palliative (P) | 2021-08-26 | 2021-09-08 | CETUXIMAB + IRINOTECAN + MDG | 99 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101018681 |
| 20214277 | 20178201 | 1.5 | 80.3 | Palliative (P) | 2021-08-17 | 2021-08-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101053354 |
| 20214280 | 20178202 | null | 103 | Palliative (P) | 2018-01-28 | 2018-10-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101103973 |
| 20214282 | 20178203 | 1.6 | 82.2 | Palliative (P) | 2019-09-05 | 2019-09-21 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101299740 |
| 20214293 | 20178204 | 1.75 | 69.05 | null | 2020-06-27 | 2020-06-27 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100326594 |
| 20214302 | 20178205 | 1.66 | 81.9 | Palliative (P) | 2020-10-14 | 2020-11-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101047594 |
| 20214326 | 20178206 | 1.67 | 80 | Palliative (P) | 2022-04-11 | 2022-04-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101082702 |
| 20214337 | 20178207 | 1.81 | 96.4 | Palliative (P) | 2020-04-05 | 2020-04-16 | CAPECITABINE + GEMCITABINE | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100617183 |
| 20214338 | 20178208 | 1.86 | 51 | null | 2022-02-11 | 2022-03-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 100085954 |
| 20214350 | 20178210 | 1.61 | 74.6 | Palliative (P) | 2022-04-07 | 2022-04-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101540692 |
| 20214372 | 20178211 | 1.81 | 55 | Palliative (P) | 2019-03-01 | 2019-03-08 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100718976 |
| 20214376 | 20178212 | 1.55 | 55 | null | 2021-01-27 | 2021-02-10 | Docetaxel | 02 | null | DOCETAXEL | 100706747 |
| 20214383 | 20178213 | 1.51 | 38.7 | null | 2021-12-08 | 2022-01-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100238147 |
| 20214395 | 20178214 | 1.69 | 79.3 | Palliative (P) | 2021-01-09 | 2021-01-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100069783 |
| 20214403 | 20178215 | 1.68 | 80.6 | Palliative (P) | 2020-01-23 | 2020-01-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100968716 |